• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Studies of the metabolism and distribution of fibrinogen in patients with hemophilia A.甲型血友病患者纤维蛋白原代谢与分布的研究。
J Clin Invest. 1967 Dec;46(12):1979-85. doi: 10.1172/JCI105687.
2
Studies of fibrinogen metabolism in healthy and hypertensive female subjects with the use of autologous I-125-fibrinogen.使用自体I-125纤维蛋白原对健康和高血压女性受试者的纤维蛋白原代谢进行的研究。
Thromb Haemost. 1978 Feb 28;39(1):39-45.
3
Some factors influencing metabolism and distribution of fibrinogen in man and rabbits.一些影响人及兔体内纤维蛋白原代谢与分布的因素。
Thromb Haemost. 1977 Apr 30;37(2):243-52.
4
Fibrinogen metabolism in cyanoti congenital heart disease.蓝氏先天性心脏病中的纤维蛋白原代谢
Haematologia (Budap). 1977;11(1-2):169-76.
5
Studies on catabolism of 125I-labelled fibrinogen in normal rabbits and in rabbits with indwelling intravenous catheters: methodologic aspects.正常兔及留置静脉导管兔体内¹²⁵I标记纤维蛋白原分解代谢的研究:方法学方面
Haemostasis. 1975;4(1):41-50.
6
Metabolism of fibrinogen in cirrhosis of the liver.肝脏肝硬化中纤维蛋白原的代谢
J Clin Invest. 1971 Aug;50(8):1690-701. doi: 10.1172/JCI106658.
7
Studies on the transcapillary escape rate of fibrinogen and capillary permeability in patients with Plasmodium falciparum malaria.恶性疟原虫疟疾患者纤维蛋白原的毛细血管逸出率及毛细血管通透性研究。
Trop Geogr Med. 1984 Jun;36(2):151-7.
8
Catabolism of human fibrinogen fragment D in normal subjects and patients with liver cirrhosis.正常人及肝硬化患者体内人纤维蛋白原片段D的分解代谢
Thromb Haemost. 1980 Dec 19;44(3):146-9.
9
Chronic intravascular coagulation. Clinical spectrum and diagnostic criteria, with special emphasis on metabolism, distribution and localization of I 131 -fibrinogen.慢性血管内凝血。临床谱及诊断标准,特别强调I 131 -纤维蛋白原的代谢、分布及定位。
Acta Med Scand Suppl. 1971;526:1-95.
10
NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).4,4'-硫代双(6-叔丁基间甲酚)(CAS编号:96-69-5)在F344/N大鼠和B6C3F1小鼠中的NTP毒理学和致癌性研究(饲料研究)
Natl Toxicol Program Tech Rep Ser. 1994 Dec;435:1-288.

引用本文的文献

1
CD8+ T cell concentration determines their efficiency in killing cognate antigen-expressing syngeneic mammalian cells in vitro and in mouse tissues.CD8+ T 细胞浓度决定了它们在体外杀伤同种抗原表达的同源哺乳动物细胞和在小鼠组织中的效率。
J Exp Med. 2010 Jan 18;207(1):223-35. doi: 10.1084/jem.20091279. Epub 2010 Jan 11.
2
The hemostasis system in murine atherosclerosis.小鼠动脉粥样硬化中的止血系统。
Curr Drug Targets. 2008 Mar;9(3):229-38. doi: 10.2174/138945008783755593.
3
Human prothrombin metabolism in normal man and in hypocoagulable subjects.正常人和低凝状态受试者的人凝血酶原代谢
J Clin Invest. 1969 Jul;48(7):1292-8. doi: 10.1172/JCI106095.
4
Plasminogen- 125 I responses in dogs to a single injection of urokinase and typhoid vaccine and to vascular injury.犬对单次注射尿激酶和伤寒疫苗以及血管损伤的纤溶酶原 - 125I反应。
J Clin Invest. 1972 Jun;51(6):1363-77. doi: 10.1172/JCI106932.

本文引用的文献

1
A study of fibrinogen turnover in classical hemophilia and congenital afibrinogenemia.经典血友病和先天性无纤维蛋白原血症中纤维蛋白原周转率的研究。
Blood. 1961 Dec;18:710-6.
2
Observations on the distribution and biological half-life of human fibrinogen.关于人纤维蛋白原分布及生物半衰期的观察
Br J Haematol. 1959 Oct;5:431-8. doi: 10.1111/j.1365-2141.1959.tb04053.x.
3
THE IN VIVO LONGEVITY OF ANTIHAEMOPHILIC FACTOR (FACTOR VIII).抗血友病因子(因子VIII)的体内寿命
Br J Haematol. 1964 Apr;10:225-37. doi: 10.1111/j.1365-2141.1964.tb00697.x.
4
THE FATE OF PROTHROMBIN AND FACTORS VIII, IX AND X TRANSFUSED TO PATIENTS DEFICIENT IN THESE FACTORS.凝血酶原以及凝血因子VIII、IX和X输注给缺乏这些因子的患者后的转归
Br J Haematol. 1963 Oct;9:532-47. doi: 10.1111/j.1365-2141.1963.tb05478.x.
5
Distribution and excretion of I-131-iodide in men on pharmacologic doses of iodides.I-131碘化物在服用药理剂量碘化物的男性体内的分布与排泄。
J Lab Clin Med. 1962 Dec;60:944-53.
6
Studies of the metabolism and distribution of albumin with autologous I131-albumin in healthy men.健康男性中白蛋白与自体I131 - 白蛋白的代谢及分布研究。
J Lab Clin Med. 1963 Feb;61:183-202.
7
Mathematical models describing the distribution of I-131-albumin in man.描述人体中碘-131-白蛋白分布的数学模型。
J Lab Clin Med. 1962 Dec;60:923-43.
8
Platelet and fibrinogen survival in normal and abnormal states of coagulation.血小板和纤维蛋白原在正常及异常凝血状态下的存活情况。
Blood. 1961 Mar;17:267-81.
9
Clotting deviations in man associated with open-heart surgery during hypothermia.低温下心内直视手术时人体凝血功能的偏差。
J Thorac Surg. 1958 Dec;36(6):857-68.
10
The turnover of plasma fibrinogen.血浆纤维蛋白原的周转率。
Acta Med Scand. 1958 Nov 27;162(5):407-14. doi: 10.1111/j.0954-6820.1958.tb01787.x.

甲型血友病患者纤维蛋白原代谢与分布的研究。

Studies of the metabolism and distribution of fibrinogen in patients with hemophilia A.

作者信息

Takeda Y, Chen A Y

出版信息

J Clin Invest. 1967 Dec;46(12):1979-85. doi: 10.1172/JCI105687.

DOI:10.1172/JCI105687
PMID:6074002
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC292950/
Abstract

Using autologous (131)I-fibrinogen, we made studies of the metabolism and distribution of fibrinogen in 10 patients with hemophilia A. In two patients simultaneous studies of autologous (131)I-fibrinogen and homologous (125)I-fibrinogen prepared from healthy donors' plasma were carried out. The average value for the plasma volume was 42.1 +/- 8.8 ml/kg; for the plasma fibrinogen concentration, 349 +/- 90 mg/100 ml; for the intravascular fibrinogen, 144 +/- 32 mg/kg; for the interstitial fibrinogen, 30 +/- 11 mg/kg; for the slower half-life of (131)I-fibrinogen, 2.34 +/- 0.17 days; for the transcapillary transfer rate of fibrinogen, 109 +/- 37 mg/kg per day; and for the catabolic and synthetic rates of fibrinogen, 51.7 +/- 13.1 mg/kg per day. Comparison of these results with those of the previous study in healthy male subjects showed that in patients with hemophilia A the catabolic and synthetic rates of fibrinogen are markedly increased, whereas the plasma fibrinogen concentration, intravascular and interstitial fibrinogen, and the transcapillary transfer rate of fibrinogen are not significantly different. The simultaneous studies of autologous (131)I-fibrinogen and normal homologous (125)I-fibrinogen in two subjects revealed that the two preparations behaved very similarly. Based on these findings, we concluded that our present findings are not due to the qualitative difference between the hemophilia A and normal fibrinogens, but that they are due to the difference in the host condition with respect to the fibrinogen metabolism, which is either an increased rate of direct breakdown of fibrinogen or an increased rate of fibrinogen breakdown after fibrin formation, or both.

摘要

我们使用自体(131)I - 纤维蛋白原对10例甲型血友病患者的纤维蛋白原代谢和分布进行了研究。其中2例患者同时进行了自体(131)I - 纤维蛋白原和由健康供体血浆制备的同源(125)I - 纤维蛋白原的研究。血浆容量的平均值为42.1±8.8ml/kg;血浆纤维蛋白原浓度为349±90mg/100ml;血管内纤维蛋白原为144±32mg/kg;间质纤维蛋白原为30±11mg/kg;(131)I - 纤维蛋白原的较慢半衰期为2.34±0.17天;纤维蛋白原的跨毛细血管转运率为109±37mg/kg/天;纤维蛋白原的分解代谢率和合成率为51.7±13.1mg/kg/天。将这些结果与之前对健康男性受试者的研究结果进行比较发现,甲型血友病患者的纤维蛋白原分解代谢率和合成率明显增加,而血浆纤维蛋白原浓度、血管内和间质纤维蛋白原以及纤维蛋白原的跨毛细血管转运率无显著差异。对2例受试者同时进行的自体(131)I - 纤维蛋白原和正常同源(125)I - 纤维蛋白原的研究表明,两种制剂的表现非常相似。基于这些发现,我们得出结论,我们目前的发现不是由于甲型血友病纤维蛋白原与正常纤维蛋白原之间的质量差异,而是由于宿主在纤维蛋白原代谢方面的条件差异,这要么是纤维蛋白原直接分解率增加,要么是纤维蛋白形成后纤维蛋白原分解率增加,或者两者兼而有之。